Assessing Self-reported Medication Adherence in Inflammatory Bowel Disease: A Comparison of Tools

Inflammatory Bowel Diseases

Volumn 22, Issue 9, 2016, Pages 2158-2164

  Severs, Mirjam ^a   Zuithoff, Peter N P A ^a   Mangen, Marie Josée J ^a   Van Der Valk, Mirthe E ^a   Siersema, Peter D ^a,b   Fidder, Herma H ^a   Oldenburg, Bas ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Crohn's disease; inflammatory bowel disease; medication adherence; self report; ulcerative colitis

Indexed keywords

8 ITEM MORISKY MEDICATION ADHERENCE SCALE; ADULT; AGE; ARTICLE; ASSESSMENT OF HUMANS; CROHN DISEASE; EMPLOYMENT STATUS; FEMALE; FOLLOW UP; FORGET MEDICINE SCALE; HEALTH BEHAVIOR; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MEDICATION COMPLIANCE; MIDDLE AGED; PRIORITY JOURNAL; SELF REPORT; ULCERATIVE COLITIS; VISUAL ANALOG SCALE; AGED; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; EMPLOYMENT; INFLAMMATORY BOWEL DISEASE; NETHERLANDS; QUESTIONNAIRE; STATISTICS AND NUMERICAL DATA;

ADULT; AGED; CROSS-SECTIONAL STUDIES; EMPLOYMENT; FEMALE; HUMANS; INFLAMMATORY BOWEL DISEASES; MALE; MEDICATION ADHERENCE; MIDDLE AGED; NETHERLANDS; SELF REPORT; SURVEYS AND QUESTIONNAIRES; VISUAL ANALOG SCALE;

EID: 84983663558     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1097/MIB.0000000000000853     Document Type: Article

References (33)

1. Kozuch PL, Hanauer SB. Treatment of inflammatory bowel disease: a review of medical therapy. World J Gastroenterol. 2008;14:354-377.
2. Kane S, Huo D, Aikens J, et al. Medication nonadherence and the outcomes of patients with quiescent ulcerative colitis. Am J Med. 2003;114:39-43.
3. Pasma A, Schenk CV, Timman R, et al. Non-adherence to diseasemodifying antirheumatic drugs is associated with higher disease activity in early arthritis patients in the first year of the disease. Arthritis Res Ther. 2015;17:281.
4. Engelkes M, Janssens HM, de Jongste JC, et al. Medication adherence and the risk of severe asthma exacerbations: a systematic review. Eur Respir J. 2015;45:396-407.
5. Herman ML, Kane SV. Treatment nonadherence in inflammatory bowel disease: identification, scope, and management strategies. Inflamm Bowel Dis. [Published online ahead of print December 21, 2015]. doi: 10.1097/ MIB.0000000000000581.
6. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005; 353:487-497.
7. Trindade AJ, Morisky DE, Ehrlich AC, et al. Current practice and perception of screening for medication adherence in inflammatory bowel disease. J Clin Gastroenterol. 2011;45:878-882.
8. Selinger CP, Eaden J, Jones DB, et al. Modifiable factors associated with nonadherence to maintenance medication for inflammatory bowel disease. Inflamm Bowel Dis. 2013;19:2199-2206.
9. van der Valk ME, Mangen M-JJ, Leenders M, et al. Healthcare costs of inflammatory bowel disease have shifted from hospitalisation and surgery towards anti-TNFa therapy: results from the COIN study. Gut. 2014;63:72-79.
10. van der Valk ME, Mangen MJJM, Severs M, et al. Evolution of costs of inflammatory bowel disease over two years of follow-up. PLoS One. 2016; 11(4):e0142481.
11. Morisky DE, Ang A, Krousel-Wood M, et al. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens (Greenwich). 2008;10:348-354.
12. Trindade AJ, Ehrlich A, Kornbluth A, et al. Are your patients taking their medicine? Validation of a new adherence scale in patients with inflammatory bowel disease and comparison with physician perception of adherence. Inflamm Bowel Dis. 2011;17:599-604. Available at: http://www. ncbi.nlm.nih.gov/pubmed/20848512. Accessed August 3, 2015.
13. Walsh JC, Mandalia S, Gazzard BG. Responses to a 1 month self-report on adherence to antiretroviral therapy are consistent with electronic data and virological treatment outcome. AIDS. 2002;16:269-277.
14. Nau DP, Steinke DT, Williams LK, et al. Adherence analysis using visual analog scale versus claims-based estimation. Ann Pharmacother. 2007;41: 1792-1797.
15. Karve S, Cleves MA, Helm M, et al. Good and poor adherence: optimal cut-point for adherence measures using administrative claims data. Curr Med Res Opin. 2009;25:2303-2310.
16. Siegel S. Nonparametric Statistics for the Behavioral Sciences. 2nd ed. New York, NY: McGraw-Hill, ed.; 1988:235.
17. Hansen RA, Kim MM, Song L, et al. Comparison of methods to assess medication adherence and classify nonadherence. Ann Pharmacother. 2009;43:413-422.
18. Garfield S, Clifford S, Eliasson L, et al. Suitability of measures of selfreported medication adherence for routine clinical use: a systematic review. BMC Med Res Methodol. 2011;11:149.
19. D'Incà R, Bertomoro P, Mazzocco K, et al. Risk factors for nonadherence to medication in inflammatory bowel disease patients. Aliment Pharmacol Ther. 2008;27:166-172.
20. Cervený P, Bortlík M, Kubena A, et al. Nonadherence in inflammatory bowel disease: results of factor analysis. Inflamm Bowel Dis. 2007;13: 1244-1249.
21. Ediger JP, Walker JR, Graff L, et al. Predictors of medication adherence in inflammatory bowel disease. Am J Gastroenterol. 2007;102:1417-1426.
22. Lopez A, Billioud V, Peyrin-Biroulet C, et al. Adherence to anti-TNF therapy in inflammatory bowel diseases: a systematic review. Inflamm Bowel Dis. 2013;19:1528-1533.
23. Lakatos PL. Prevalence, predictors, and clinical consequences of medical adherence in IBD: how to improve it? World J Gastroenterol. 2009;15: 4234-4239.
24. Kane S, Becker B, Harmsen WS, et al. Use of a screening tool to determine nonadherent behavior in inflammatory bowel disease. Am J Gastroenterol. 2012;107:154-160.
25. Murota H, Takeuchi S, Sugaya M, et al. Characterization of socioeconomic status of Japanese patients with atopic dermatitis showing poor medical adherence and reasons for drug discontinuation. J Dermatol Sci. 2015;79:279-287.
26. Pandey A, Raza F, Velasco A, et al. Comparison of Morisky Medication Adherence Scale with therapeutic drug monitoring in apparent treatmentresistant hypertension. J Am Soc Hypertens. 2015;9:420-426.e2.
27. ChungWW, Chua SS, Lai PSM, et al. The Malaysian medication adherence scale (MALMAS): concurrent validity using a clinical measure among people with type 2 diabetes in Malaysia. PLoS One. 2015;10:e0124275.
28. Saeki H, Imafuku S, Abe M, et al. Poor adherence to medication as assessed by the Morisky Medication Adherence Scale-8 and low satisfaction with treatment in 237 psoriasis patients. J Dermatol. 2015;42:367-372.
29. Gallagher BD, Muntner P, Moise N, et al. Are two commonly used selfreport questionnaires useful for identifying antihypertensive medication nonadherence? J Hypertens. 2015;33:1108-1113.
30. Lehane E, McCarthy G. Intentional and unintentional medication nonadherence: a comprehensive framework for clinical research and practice? A discussion paper. Int J Nurs Stud. 2007;44:1468-1477.
31. Garber MC, Nau DP, Erickson SR, et al. The concordance of self-report with other measures of medication adherence: a summary of the literature. Med Care. 2004;42:649-652.
32. Hugen PWH, Langebeek N, Burger DM, et al. Assessment of adherence to HIV protease inhibitors: comparison and combination of various methods, including MEMS (electronic monitoring), patient and nurse report, and therapeutic drug monitoring. J Acquir Immune Defic Syndr. 2002;30: 324-334.
33. Cramer JA, Scheyer RD, Mattson RH. Compliance declines between clinic visits. Arch Intern Med. 1990;150:1509-1510.